Compounded versions, while legal under certain circumstances, can erode the market exclusivity that brand-name manufacturers rely on
GLP-1 medications include tirzepatide and semaglutide
Health Canada typically reviews new drug applications following FDA approval, adding 6-18 months to Canadian availability timelines
This gradual build-up ensures that your internal systems adapt safely before targeting maximum fat loss
Nevertheless, in a network meta-analysis comparing short-acting and long-acting GLP-1RAs when used in conjunction with basal insulin, long-acting GLP-1RAs resulted in significantly greater reductions in glycated hemoglobin (HbA1c), fasting plasma glucose, and body weight compared to short-acting GLP-1RAs, with better gastrointestinal tolerability [15]
Unlike older secretagogues, Ipamorelin demonstrates strong receptor specificity in research models